Imara presents preclinical data on imr-261 at the american society of hematology (ash) annual meeting 2021

Oral presentation provides first look at new program, imr-261, a novel, oral, clinic-ready nuclear factor erythroid 2-related factor 2 (nrf2) activator

ELVN Ratings Summary

ELVN Quant Ranking